Company news
Ventripoint Diagnostics Ltd. (TSXV:VPT) news
Ventripoint Diagnostics Ltd. news releases on 6ix. Latest, Apr 25, 2023: Ventripoint Announces Sponsorship of the 56th Annual Meeting of the Association…
Press releases — page 4
Ventripoint Announces Sponsorship of the 56th Annual Meeting of the Association for European Paediatric and Congenital Cardiology
April 25, 2023
Ventripoint Diagnostics Provides a Corporate Update
March 16, 2023
Ventripoint Diagnostics Announces Dr. Alvira Macanovic as President and CEO
January 2, 2023
Ventripoint Diagnostics Provides a Corporate Update and Announces New Investor Relations Initiative
December 14, 2022
Ventripoint Signs on Arc Group Medical LLC as Distributor in Florida Region
November 30, 2022
Ventripoint Appoints MediTek Lifesciences LLC as Distributor for California
November 17, 2022
Ventripoint to Sponsor the Annual Meeting of the British Congenital Cardiac Association
November 4, 2022
Ventripoint Diagnostics Exhibiting at the 2022 British Society of Echocardiography
October 14, 2022
Ventripoint Announces Sponsorship for the European Society of Cardiology Congress 2022
August 26, 2022
Echocardiologists in Latin America Express Strong Interest in Ventripoint Whole Heart Analysis Products
August 10, 2022
Single Ventricle Congenital Heart Disease Study Launches at Leading Academic Medical Center using Ventripoint's VMS+3.0 Whole-Heart Analysis System
June 29, 2022
Ventripoint Exhibiting at the American Society of Echocardiography 33rd Annual Scientific Session
June 7, 2022
Ventripoint Announces Sponsorship of the 55th Annual Meeting of the Association for European Paediatric and Congenital Cardiology
May 17, 2022
Ventripoint Hires Two Strategic Sales Account Managers for US, Europe, and UK Distribution
May 9, 2022
Ventripoint Announces Sponsorship for the 2022 SickKids Echo Symposium
May 3, 2022
Ventripoint Welcomes Dr. Jose Banchs as New Clinical Advisor
April 27, 2022
Ventripoint Welcomes Dr. Howard Michael Leong-Poi as New Clinical Advisor
April 19, 2022
Ventripoint Signs on AngioConsult/Angiopro as European Distributor
April 7, 2022
Ventripoint to Exhibit at the American College of Cardiology 71st Annual Scientific Session and Expo and Correction to North Equities Corp Grant of Stock Options
April 1, 2022
Ventripoint Announces DTC Eligibility Approval in the U.S.
March 21, 2022
Ventripoint Hires Social Media Firm North Equities Corp.
March 2, 2022
Ventripoint and at the Mazankowski Heart Institute to Collaborate to Conduct a World-First Study of the Changes in Cardiac Function during Pregnancy
March 1, 2022
Ventripoint Announces Sponsorship for 24th Annual Canadian Society of Echocardiography Echo Weekend
February 3, 2022
Ventripoint Appoints Dr. Gregory Skinner to Board of Clinical Advisors
February 2, 2022
Ventripoint Hires Iconic Investor Relations LLC to Provide Investor Relations Services
January 27, 2022
Ventripoint Successfully Completes European Commission QMS Certification Surveillance Audit
January 24, 2022
Ventripoint Issues Option Grants and Reports Exercise of Options and Warrants
January 21, 2022
Ventripoint Announces Up-Listing to OTCQB Venture Market
January 7, 2022
Ventripoint Successfully Renews QMS Certification
December 29, 2021
Ventripoint Expands United Kingdom Marketing with New Distribution Partner CardioLogic
December 21, 2021
Ventripoint Appoints Randy AuCoin to Board of Directors
December 20, 2021
Ventripoint Receives Additional Funding to Develop Next Generation of the VMS+, Whole-Heart Analysis System
December 6, 2021
Ventripoint Applauds the US Government for Establishing an Additional Payment to Doctors for Analyzing 3D Heart Scans
November 29, 2021
Ventripoint Selected by Life Sciences Ontario as 2021 Success Story
November 24, 2021
Ventripoint Provides Corporate Update on Market Adoption of VMS+ Whole-heart Analysis System
November 22, 2021
Ventripoint Passes Audit of Manufacturing Facility for Canadian and US Markets
November 9, 2021
Ventripoint Appoints Fiona Fitzgerald to the Board of Directors
October 25, 2021
Ventripoint Installs VMS+ 3.0 Unit at East Midlands Congenital Heart Centre
October 21, 2021
Ventripoint Diagnostics Ltd. Announces Closing of Upsized Bought Deal Offering of Units
October 20, 2021
Ventripoint Diagnostics Ltd. Announces Filing of Second Amended and Restated MD&A
October 13, 2021
Ventripoint Diagnostics Ltd. Announces Filing of Amended and Restated Interim Financial Statements and MD&A
October 1, 2021
Ventripoint Diagnostics Ltd. Announces Upsize to Previously Announced Bought Deal Offering of Units to $7 Millon
September 28, 2021
IIROC Trading Resumption - VPT
September 28, 2021
Ventripoint Diagnostics Ltd. Announces $5 Million Bought Deal Offering of Units
September 27, 2021
IIROC Trading Halt - VPT
September 27, 2021
Ventripoint Issues Option Grants to Consultant
September 17, 2021
Ventripoint Provides Update on Clinical Studies
September 15, 2021
Ventripoint Provides Update on Growth Initiatives and Sales
September 14, 2021
Ventripoint Issues Option Grants to Consultants and Reports Options Exercise
September 7, 2021
Ventripoint Reports Second Quarter 2021 Financial Statements and MD&A
September 3, 2021